Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) can cure bone marrow failure in patients with Fanconi anemia (FA). Data on outcomes in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome (MDS), or acute leukemia have not been separately analyzed. PATIENT...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ayas, Mouhab, Saber, Wael, Davies, Stella M., Harris, Richard E., Hale, Gregory A., Socie, Gerard, LeRademacher, Jennifer, Thakar, Monica, Deeg, H. Joachim J., Al-Seraihy, Amal, Battiwalla, Minoo, Camitta, Bruce M., Olsson, Richard, Bajwa, Rajinder S., Bonfim, Carmem M., Pasquini, Ricardo, MacMillan, Margaret L., George, Biju, Copelan, Edward A., Wirk, Baldeep, Al Jefri, Abdullah, Fasth, Anders L., Guinan, Eva C., Horn, Biljana N., Lewis, Victor A., Slavin, Shimon, Stepensky, Polina, Bierings, Marc, Gale, Robert Peter
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2013
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3635221/
https://ncbi.nlm.nih.gov/pubmed/23547077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.45.9719
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars